Overview and Scope
Esophageal cancer refers to a type of cancer that arises in the cells lining the esophagus, the muscular tube that carries food and drinks from the neck to the stomach. This occurs when abnormal cells in the food pipe (esophagus) develop uncontrollably and cause cancer.
Sizing and Forecast
The esophageal cancer market size has grown rapidly in recent years. It will grow from $1.25 billion in 2023 to $1.38 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increased number of cancer, improvement in healthcare infrastructure, rise in alcohol consumption, growth in demand for preventive healthcare solutions, increase in prevalence of esophageal adenocarcinoma.
The esophageal cancer market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to rising prevalence of esophageal cancer, increasing public understanding of healthcare, improvements in healthcare infrastructure, chronic consumption of smoking and alcohol, increasing prevalence of esophageal adenocarcinoma. Major trends in the forecast period include technological advancements in treatment options, increased investment in research and development, increasing utilization of precision medicine, development of targeted therapies, increased participation in clinical trials and collaborations between academia, pharmaceutical companies, and healthcare institutions.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report
Segmentation & Regional Insights
The esophageal cancer market covered in this report is segmented –
1) By Type: Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types
2) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users
North America was the largest region in the esophageal cancer market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12637&type=smp
Major Driver Impacting Market Growth
An increase in esophageal cancer is expected to propel the esophageal cancer market growth. Esophageal cancer is a malignancy that affects the esophagus, the tube-like structure connecting the throat to the stomach. As the incidence of esophageal cancer increases, there will be a higher demand for diagnostic procedures, such as endoscopy, imaging tests, and biopsies, to detect and confirm the presence of the disease. For instance, in February 2023, according to the National Library of Medicine, a US-based medical library operated by the American government, the incidence rate of esophageal adenocarcinoma among individuals aged 40-65 is projected to rise from 2.12 per 100,000 persons in 2021 to 3.86 per 100,000 persons in 2040. This represents an 82% increase over 19 years, equivalent to a yearly growth rate of 3.2%. Therefore, the increase in esophageal cancer is expected to drive the growth of the esophageal cancer market.
Key Industry Players
Major companies operating in the esophageal cancer market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Servier Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., Aslan Pharmaceuticals Ltd.
The esophageal cancer market report table of contents includes:
1. Executive Summary
2. Esophageal Cancer Market Characteristics
3. Esophageal Cancer Market Trends And Strategies
4. Esophageal Cancer Market – Macro Economic Scenario
5. Global Esophageal Cancer Market Size and Growth
.
.
.
31. Esophageal Cancer Market Other Major And Innovative Companies
32. Global Esophageal Cancer Market Competitive Benchmarking
33. Global Esophageal Cancer Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Esophageal Cancer Market
35. Esophageal Cancer Market Future Outlook and Potential Analysis
36.Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
